Gelesis Holdings
Boston, US · Founded 2020
Biotech
Founders & leadership
DA
David AbrahamExecutive Officer
AS
Alessandro SanninoExecutive Officer
AB
Alison BauerleinDirector
JW
Jane WildmanDirector
DP
David PassExecutive Officer
RK
Raju KucherlapatiDirector
EC
Elaine ChiquetteExecutive Officer
HL
Harry L. LeiderExecutive Officer
DP
Dominic PerksDirector
KC
Kathryn CavanaughDirector
YZ
Yishai ZoharExecutive Officer, Director
PF
Paul FonteyneDirector
Reported raises · per SEC filings
Form D private placements▶$575.7KraisedAug 2022 · 1 investors · PharmaceuticalsRule 506(b)
▶$575.7KraisedAug 2022 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David AbrahamExecutive Officer
- Alessandro SanninoExecutive Officer
- Alison BauerleinDirector
- Jane WildmanDirector
- David PassExecutive Officer
- Raju KucherlapatiDirector
- Elaine ChiquetteExecutive Officer
- Harry L. LeiderExecutive Officer
- Dominic PerksDirector
- Kathryn CavanaughDirector
- Yishai ZoharExecutive Officer, Director
- Paul FonteyneDirector
- Clayton ChristopherDirector
- Elliot MaltzExecutive Officer
- Offering amount
- $50.6M
- Amount sold
- $575.7K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.